Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness
about
Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification.Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.
P2860
Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@ast
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@en
type
label
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@ast
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@en
prefLabel
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@ast
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@en
P2860
P1433
P1476
Erlotinib augmentation with da ...... ased anti-cancer effectiveness
@en
P2093
P2860
P2888
P356
10.1186/S40064-015-1441-5
P577
2015-10-23T00:00:00Z
P5875
P6179
1016427681